All Resources
Paper Summary
Characterizing T Cell Exhaustion and Hypofunctionality in Cancer

In a paper published in Science Translational Medicine, researchers outlined how they used our IsoCode® Single-Cell Secretome platform to study the CD8+ T cell landscape in glioblastoma (GBM).

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Paper Summary we discuss:

Spanning the spectrum of T cell dysfunction.
Characterizing tolerized CD8+ T cell chemokines.
Uncovering the CD8+ T cell states behind ICB-non-responsive tumors.
A Deeper Look

More about this Paper Summary

Paving the Road to Optimized Immunotherapies

This study provides a path forward for future research of immunotherapies targeting low-immunogenicity cancers, including non-responsive tumors such as GBM.

Download this paper summary to learn more!

Get the Paper Summary